Clinical trial

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

NCT00465803

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Travoprost 0.004%/timolol 0.5% ophthalmic solution Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Travoprost ophthalmic solution, 0.004% Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Timolol maleate ophthalmic solution, 0.5% Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-03-01

PhasePHASE3

Conditions

Open-angle Glaucomaverified · MONDO: open-angle glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

Travoprost 0.004%/timolol 0.5% ophthalmic solutionDRUG

Travoprost ophthalmic solution, 0.004%DRUG

Timolol maleate ophthalmic solution, 0.5%DRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00465803 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.